Clinipace Worldwide Acquires Regulus Pharmaceutical Consulting, Inc.
Published: Mar 01, 2011
MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today the acquisition of Regulus Pharmaceutical Consulting, Inc., a Regulatory Affairs and Quality Assurance consultancy based in Boulder, Colorado. With this acquisition, Clinipace Worldwide significantly expands its regulatory and strategic development expertise. The company has increased its staff by 20 percent with new team members adding an average of 18 years experience in the life science industry. The Regulus team will remain in Boulder, CO with the same management structure and personnel; and will operate as the Regulatory Affairs, Strategic Development, and Quality Assurance consultancy division of Clinipace Worldwide. In addition, the company further expands its in-house regulatory publishing and medical writing groups through the Regulus acquisition.